dbACP: A Comprehensive Database of Anti-Cancer Peptides

12 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp08417 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay U343 Glioblastoma IC50 = 0.781 μM
dbacp08418 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay U373MG Glioblastoma IC50 = 0.8717 μM
dbacp08419 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay U251 Glioblastoma IC50 = 0.7607 μM
dbacp08420 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay U87-MG Glioblastoma IC50 = 0.9164 μM
dbacp08421 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay HepG-2 Liver Cancer IC50 = 3.064 μM
dbacp08422 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay Hep3B Liver Cancer IC50 = 0.7847 μM
dbacp08423 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay 293T Renal Cancer IC50 = 1.107 μM
dbacp08424 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay MCF-7 Breast Cancer IC50 = 9.74 μM
dbacp08425 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay MDA-MB-231 Breast Cancer IC50 = 0.8061 μM
dbacp08426 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay HL-60 Blood Cancer IC50 = 1.111 μM
dbacp08427 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay K-562 Blood Cancer IC50 = 1.103 μM
dbacp08428 5-2C NYPQRPCRGDKGPDC Synthetic Not Available MTT assay Hel Blood Cancer IC50 = 1.055 μM